Clinical Trial Update: A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Substance P-Saporin in terminally ill patients with histologically confirmed advanced cancer and intractable pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Substance P-Saporin (Substance P-Saporin)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Terminally Ill, Histologically-confirmed Advanced Cancer | Phase 1 | Status: COMPLETED